Kenyan Health Patient Information Leaflet
Beta-2 adrenergic agonist (bronchodilator)
Productive cough that is associated with bronchospasm such as bronchitis, bronchial asthma, chronic obstructive pulmonary disease, bronchiectasis and emphysema. Clinical selection for Ambroxol HCL, Salbutamol, Guaiphenesin, Menthol flavor should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Beta-2 adrenergic agonist (bronchodilator). Confirm site-specific dose, duration and monitoring before prescribing.
Dosing is indication-, age-, weight- and organ-function-specific for this INN. Do not use class averages for high-risk patients. Confirm the exact regimen in the current SmPC and Kenya Standard Treatment Guidelines. Typical professional workflow: (1) confirm indication, (2) check renal/hepatic function, (3) screen interactions/allergies, (4) select dose/route/duration, (5) define monitoring.
Tremor, tachycardia, headache, palpitations, hypokalaemia, hyperglycaemia. Serious: arrhythmias, paradoxical bronchospasm.
Store as labelled. Keep out of reach of children.